focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 167.50
Bid: 165.00
Ask: 170.00
Change: 0.00 (0.00%)
Spread: 5.00 (3.03%)
Open: 167.50
High: 167.50
Low: 167.50
Prev. Close: 167.50
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement - Result of Placing and Subscription

24 Nov 2022 12:54

RNS Number : 5358H
Helios Underwriting Plc
24 November 2022
 

The following amendment has been made to the 'Result of Placing and Subscription' announcement released on 24 November 2022 at 7.00 a.m. under RNS No 4228H

The word "million" was erroneously included in the third paragraph and has been removed in the below announcement.

All other details remain unchanged.

The full amended text is shown below.

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

24 November 2022

Helios Underwriting plc

("Helios", "Company" or the "Group")

 

Result of Placing and Subscription

 

Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's, is pleased to announce that, following the announcement released on 23 November 2022 ("Announcement"), it has successfully raised gross proceeds of approximately £12.5 million through a placing of, and a subscription for, an aggregate of 8,043,927 New Ordinary Shares at a price of £1.56 per share.

 

A total of 7,843,927 New Ordinary Shares have been placed at the Issue Price with investors pursuant to the Placing, thereby conditionally raising approximately £12.2 million, subject to Shareholder approval. 

 

In addition, a total of 200,000 New Ordinary Shares have been subscribed for under the Subscription at the Issue Price, thereby raising £312,000, subject to Shareholder approval.

 

The Announcement also confirmed that the Company proposes to raise up to a further approximately £1.5 million by way of a conditional open offer of 984,088 Open Offer Shares to Qualifying Shareholders at the Issue Price, subject to Shareholder approval.

 

The Placing, Subscription and Open Offer are all conditional, inter alia, upon the passing of certain Resolutions. Accordingly, the Circular is expected to be posted later today, notifying Shareholders of the General Meeting on 13 December 2022.

 

The Placing was conducted by way of an accelerated book build process. Shore Capital acted as sole broker on the Placing.

 

The Issue Price represents a discount of approximately 0.3 per cent. to the closing price of £1.565 per share on 22 November 2022.

 

Application will be made for the admission of the Placing Shares, the Subscription Shares and the Open Offer Shares to trading on AIM and dealings in the Placing Shares, Subscription Shares and Open Offer Shares are expected to commence at 8.00 a.m. on 14 December 2022 (or such later date, being not later than 8.00 a.m. on 31 December 2022, as the Company and Shore Capital may agree). The Placing Shares, Subscription Shares and Open Offer Shares, when issued, will rank pari passu with the Existing Ordinary Shares.

 

Director's Participation

The interests (all of which are beneficial unless stated otherwise) of the Directors, and their respective immediate families and of persons connected with them (within the meaning of section 252 of the Act) in the Existing Ordinary Shares as at the Latest Practicable Date and as they are expected to be following Admission (assuming that the Placing Shares, the Subscription Shares and the maximum number of Open Offer Shares are issued) are as follows:

At the Latest Practicable Date

Participation in the Placing or Subscription

Expected Open Offer Participation

Immediately following Admission

Name

Number of Ordinary Shares

Percentage of Existing Ordinary Shares

Number of Placing Shares or Subscription Shares

Number of Open Offer Shares

Number of Ordinary Shares

Percentage of Enlarged Share Capital****

Michael Cunningham

86,848

0.13%

200,000

-

286,848

0.37%

Nigel Hanbury*

9,549,794

13.86%

12,564

-

9,562,358

12.27%

Arthur Manners**

1,187,368

1.72%

-

16,962

1,204,330

1.55%

Andrew Christie

34,317

0.05%

-

-

34,317

0.04%

Edward Fitzalan-Howard

382,864

0.56%

-

-

382,864

0.49%

Martin Reith

130,161

0.19%

127,566

-

257,727

0.33%

Tom Libassi***

13,407,000

19.46%

-

-

13,407,000

17.21%

 

* 622,500 of Nigel Hanbury's Ordinary Shares are jointly owned in accordance with the Company's Joint Share Ownership Plan - 300,000 of which are detailed in the announcement made by the Company on 14 December 2017 and 322,500 of which are detailed in the announcement made by the Company on 17 August 2021.

** 477,500 of Arthur Manner's shares are jointly owned in accordance with the Company's Joint Share Ownership Plan, 200,000 of which are detailed in the announcement made by the Company on 14 December 2017 and 277,500 of which are detailed in the announcement made by the Company on 17 August 2021.

*** Tom Libassi does not hold Ordinary Shares in the Company but is the Co-founder and Managing Partner of Resolute Global Partners Limited, which funds under management of, or associated with, holds 13,407,000 Ordinary Shares.

**** On the basis that the Open Offer is taken up in full.

A copy of the Circular will shortly be available on the Company's website at www.huwplc.com.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (ED No.596/2014) (and all delegated regulations, implementation directives, technical standards and guidance issued by European Securities and Markets Authority from time to time, as implemented in the UK by the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal) Act 2020)) ("UK MAR"), encompassing information relating to the Placing, the Subscription and the Open Offer as described above, and is disclosed in accordance with the Company's obligations under Article 17 of UK MAR.

 

For further information please contact:

 

Helios Underwriting plc

Nigel Hanbury - Chief Executive +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Shore Capital (Nomad and Broker)

Robert Finlay +44 (0)20 7408 4080

David Coaten

Henry Willcocks

 

Gallagher (Financial Adviser) +44 (0)20 3124 6033

Deepon Sen Gupta

Alastair Rodger

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £232 million of underwriting capacity for the 2022 year of account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMZMZDZGZZM
Date   Source Headline
11th May 20217:00 amRNSHolding(s) in Company
27th Apr 202112:57 pmEQSHardman & Co Research : Hardman & Co Video Event | Helios Underwriting Plc - Investor Forum
27th Apr 20217:00 amRNSHolding(s) in Company
21st Apr 20217:00 amRNSDirectorate Changes
20th Apr 202111:35 amRNSHolding(s) in Company
1st Apr 202112:34 pmRNSResult of GM, TVR and Directors' Participation
1st Apr 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
30th Mar 20217:00 amRNSResult of Open Offer
11th Mar 20217:00 amRNSDirector/PCA Shareholding
9th Mar 20217:00 amRNSResult of Placing and Subscription
8th Mar 20214:45 pmRNSFundraising to raise up to approximately £60m
16th Feb 20211:37 pmRNSRevision to Adjusted Net Asset Value
8th Feb 20217:00 amRNSDirectorate Change
2nd Feb 20217:00 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSAppointment of Financial Adviser
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSMaterial Capacity Increase
30th Nov 20209:57 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
26th Nov 20203:40 pmRNSResult of GM, TVR and Directors' Participations
24th Nov 20207:00 amRNSResult of Open Offer
19th Nov 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
2nd Nov 20207:00 amRNSPlacing, Subscription, Open Offer & Acquisitions
7th Oct 20207:00 amRNSProposed Fundraising
25th Sep 20207:00 amRNSHalf-year Report
17th Aug 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
10th Aug 20207:00 amRNSUpdate on Capacity and Growth Plans
25th Jun 202012:38 pmRNSResult of AGM
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 202012:28 pmRNSHolding(s) in Company
1st Jun 20207:30 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSFinal results for the year ended 31 December 2019
30th Mar 20207:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20207:00 amRNSCapacity Update and Transaction in Own Shares
13th Dec 20197:00 amRNSAcquisition
18th Nov 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
7th Oct 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20199:39 amRNSReplacement- Transaction in Own Shares
2nd Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20197:00 amRNSTransaction in Own Shares
16th Aug 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
15th Aug 20194:28 pmRNSHolding(s) in Company
12th Aug 20197:00 amRNSProposed Ordinary Share repurchases
19th Jul 20198:47 amRNSHolding(s) in Company
16th Jul 20191:00 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.